Search results for “Dolutegravir”

About 2 results in articles

Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing articles matching Dolutegravir — open any to read the full text, or download the PDF or XML.

2 articles

Dolutegravir: Pharmacokinetics and Pregnancy Profile

Mar 2022
Gudisa BeredaCorresponding author

Dolutegravir suppresses this integration enzyme, so human immune virus can’t create every greater copies of itself, thus ‘’integrase inhibitor.’’ Dolutegravir is hastily absorbed pursuing oral administration. The median maximum plasma concentration is reached 1.5–2.5 hours after oral uptake with a m…

Characterization of People Receiving 2-Drug Regimens (2DR) for HIV Management in Italy

Mar 2026 DOI 10.14302/issn.2994-6743.ijstd-26-6060
Pier Francesco AmadeoCorresponding author

Objective To describe the clinical features and real-world treatment of people living with human immunodeficiency virus (PLHIV) using fixed-dose or free combinations of 2-drug regimens (2DR) of antiretroviral therapy (ART). Design Italian retrospective cohort study. Methods Data were extracted from…

Frequently asked questions

Are these articles peer-reviewed?
Yes. Articles published at Open Access Pub go through single-blind peer review (double-blind on request) under an editorial board before publication.
Are the articles free to read?
Yes. Every article is open access — read the full text online for free and download the PDF or XML, with no paywall or subscription.
How do I cite an article?
Use the DOI shown on each result and on the article page; it is the permanent, citable link to the article.
How do I read or download an article?
Click "Read full text" to open the article HTML, or use the PDF / XML buttons on each card to download it.